Physician

Iqbal Masood, MD

According to 2025 Medicare claims, Iqbal Masood, MD (NPI: 1013176759) practices nephrology in the Grand Forks, ND-MN market, with the plurality of this provider's patient population coming from Grand Forks, ND. This provider's primary affiliated billing organization is ALTRU HEALTH SYSTEM (NPI: 1043309552; TIN: 450310462) and primary practice location at 58201-4036. Masood is affiliated with the Caravan Collaborative Pathways (ACO ID: A4604), Caravan Health ACO 50 LLC (ACO ID: A5160), CVS ACO (ACO ID: A5407), and CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Masood's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 836 traditional Medicare patients, billed 3,974 HCPCS/CPT codes, and received $327,972 in Medicare payments. The top billing code was 99222 (Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes). Part D data shows 8,962 prescription claims across 868 beneficiaries totaling $342,871 in drug costs, led by Kerendia (Finerenone). DME data shows 151 claims. No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $139,528 to $327,972. Similarly, Part D prescription costs have moved from a lower plateau to a higher plateau, from $98,308 to $342,871. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	361	1,587	$139,528
2016	426	2,027	$160,739
2017	496	2,364	$177,276
2018	559	2,957	$198,558
2019	730	3,590	$251,839
2020	747	3,520	$236,921
2021	775	3,614	$276,689
2022	836	3,847	$287,046
2023	838	3,416	$318,725
2024	836	3,974	$327,972

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	220	1,189	$98,308
2016	308	3,144	$169,718
2017	367	4,240	$138,736
2018	443	5,675	$155,317
2019	538	6,587	$266,054
2020	530	6,506	$228,200
2021	598	6,768	$269,286
2022	742	7,821	$304,007
2023	854	8,148	$372,306
2024	868	8,962	$342,871

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	39	$874
2019	N/R	70	$2,961
2020	N/R	88	$4,948
2021	N/R	116	$9,881
2022	N/R	103	$4,114
2023	N/R	168	$13,099
2024	N/R	151	$6,668

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99222	Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes	114	127	$91
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	543	1,019	$71
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	233	945	$58
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	117	124	$45
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	320	457	$12

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Kerendia	Finerenone	85	2,422	$49,805
Farxiga	Dapagliflozin Propanediol	89	2,446	$44,990
Jardiance	Empagliflozin	54	1,551	$31,749
Bumetanide	Bumetanide	721	29,607	$25,358
Lokelma	Sodium Zirconium Cyclosilicate	13	728	$16,175

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J7503	Tacrolimus, extended release, (envarsus xr), oral, 0.25 mg	N	N/R	12	$4,742
J7517	Mycophenolate mofetil, oral, 250 mg	N	N/R	33	$606
Q0511	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period	N	N/R	33	$565
Q0512	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day period	N	N/R	47	$552
J7507	Tacrolimus, immediate release, oral, 1 mg	N	N/R	26	$204

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

Explore More Providers

FAQ

What Medicare data is available for Iqbal Masood, MD?

Tedicare shows public-source Medicare data for Iqbal Masood, MD (NPI 1013176759), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Iqbal Masood, MD have ACO affiliation data?

Iqbal Masood, MD is shown with ACO affiliation data for Caravan Collaborative Pathways (MSSP, ACO ID A4604), Caravan Health ACO 50 LLC (MSSP, ACO ID A5160), CVS ACO (MSSP, ACO ID A5407), and CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to Iqbal Masood, MD?

Iqbal Masood, MD is linked to ALTRU HEALTH SYSTEM (billing NPI 1043309552) in the available physician profile data.

Does Iqbal Masood, MD have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.